# A Study of TAK-360 in People With Narcolepsy or Idiopathic Hypersomnia

> **NCT07646678** · PHASE2,PHASE3 · RECRUITING · sponsor: **Takeda** · enrollment: 500 (estimated)

## Conditions studied

- Idiopathic Hypersomnia
- Narcolepsy Type 1
- Narcolepsy Type 2

## Interventions

- **DRUG:** TAK-360
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT07646678
- **Lead sponsor:** Takeda
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-06-11
- **Primary completion:** 2031-06-15
- **Final completion:** 2031-06-15
- **Target enrollment:** 500 (ESTIMATED)
- **Last updated:** 2026-09-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07646678

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07646678, "A Study of TAK-360 in People With Narcolepsy or Idiopathic Hypersomnia". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07646678. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*